CA$9.06+20.96% · 3M
Moving avg
1W+3.19%
1M+2.95%
3M+20.96%
6M+23.60%
YTD-8.67%
1Y-9.22%
3Y-20.32%
5Y-75.51%
52-week range
$4.4159% of range$8.01
Company health
Value3/6
Growth1/6
Profitability4/6
Health3/6
Dividend0/6
Bull vs bear
Strengths
- High return on equity (8877%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$2.45B
Enterprise value
$15.46B
P/E ratio (TTM)
-2.21x
P/S ratio (TTM)
0.22x
EV/EBITDA
10.45x
Per share & returns
EPS (TTM)
-$2.12
Dividend yield
0.00%
Beta (1Y)
0.43
30-day change
+2.95%
Trading
Volume (24h)
228.25K
Previous close
CA$9.32
Shares outstanding
373.99M
About Bausch Health Companies Inc.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
TSX
Symbol
BHC.TO
Bausch Health Companies Inc. is a mid-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry.
Frequently asked questions
What is Bausch Health Companies Inc.'s market cap?
Bausch Health Companies Inc. (BHC.TO) has a market capitalization of $2.45B.
What sector is Bausch Health Companies Inc. in?
Bausch Health Companies Inc. operates in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
What exchange does BHC.TO trade on?
BHC.TO trades on TSX.
Appears in
Eli Lilly and CompanyLLY
$1,148.20-0.98%
$1.08T cap
Johnson & JohnsonJNJ
$275.23-1.15%
$663.28B cap
AbbVie Inc.ABBV
$256.34-1.49%
$452.90B cap
Merck & Co., Inc.MRK
$150.34-1.31%
$371.31B cap
UnitedHealth Group IncorporatedUNH
$397.14-0.95%
$360.66B cap
Roche Holding AGSWX: ROP
CHF 357.00+0.14%
$350.91B cap
Novartis AGSWX: NOVN
CHF 129.58-1.33%
$304.13B cap
AstraZeneca PLCLON: AZN
£120.06-1.15%
$251.66B cap